1. Clinical Overview
A fixed-dose combination (FDC) of a tricyclic antidepressant (TCA), Amitriptyline, and a benzodiazepine, Chlordiazepoxide. Primarily used for the management of mixed anxiety-depressive disorders, where both components act synergistically. Amitriptyline elevates mood by inhibiting the reuptake of serotonin and norepinephrine, while Chlordiazepoxide provides rapid anxiolytic and sedative effects by potentiating GABAergic neurotransmission. This combination is particularly useful in patients where anxiety is a prominent feature of depression. Its use is now more restricted due to the risk of dependence, sedation, and anticholinergic side effects, and it is generally considered a second-line or short-term option.
| Onset | Duration | Bioavailability |
|---|---|---|
| Chlordiazepoxide: 30-60 minutes (anxiolytic). Amitriptyline: Antidepressant effect takes 2-4 weeks, though sedative effects may be seen within hours. | Chlordiazepoxide: Intermediate-acting (half-life of active metabolites 24-48 hours). Amitriptyline: Long-acting (half-life 10-28 hours). | Amitriptyline: ~40-60% (significant first-pass metabolism). Chlordiazepoxide: >90% (well absorbed). |
2. Mechanism of Action
The combination provides a dual mechanism: Amitriptyline treats the core depressive symptoms by blocking the reuptake of serotonin (5-HT) and norepinephrine (NE) at presynaptic terminals, increasing their availability in the synaptic cleft. Chlordiazepoxide provides immediate relief from anxiety and agitation by allosterically modulating the GABA-A receptor, increasing the frequency of chloride channel opening, leading to neuronal hyperpolarization and CNS depression.
3. Indications & Uses
- Mixed Anxiety and Depressive Disorder (MADD)
- Depression with prominent anxiety or agitation
- Severe anxiety disorders (short-term adjunct)
4. Dosage & Administration
Adult Dosage: Initially, 1 tablet (Amitriptyline 25mg + Chlordiazepoxide 10mg) at bedtime. May be increased to 1 tablet twice daily (morning and bedtime) based on response and tolerance. Maximum usually 2 tablets per day. Treatment should be initiated at the lower possible dose.
Administration: Take orally with or without food. Taking at bedtime minimizes daytime sedation. Tablet can be split for dose titration. Do not crush or chew unless advised. Avoid abrupt discontinuation; taper dose gradually over weeks to prevent withdrawal symptoms (especially from Chlordiazepoxide).
5. Side Effects
Common side effects may include:
- Drowsiness, sedation
- Dry mouth (xerostomia)
- Constipation
- Blurred vision
- Dizziness, lightheadedness
- Weight gain
- Increased appetite
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - Phenelzine, Tranylcypromine | Risk of serotonin syndrome, hyperpyrexia, seizures, death. | Contraindicated |
| Other CNS Depressants (Alcohol, Opioids, Barbiturates, other Benzodiazepines) | Profound additive CNS and respiratory depression, sedation, risk of death. | Major |
| Anticholinergics (Atropine, Trihexyphenidyl, some antipsychotics) | Additive anticholinergic effects: severe dry mouth, constipation, urinary retention, confusion. | Major |
| Enzyme Inhibitors (CYP2C19/CYP2D6/CYP3A4) - Fluoxetine, Fluvoxamine, Cimetidine, Ketoconazole | Increased plasma levels of Amitriptyline/Chlordiazepoxide, leading to toxicity. | Major |
| Enzyme Inducers (CYP3A4) - Phenytoin, Carbamazepine, Rifampicin | Decreased plasma levels, reduced efficacy. | Moderate |
| Antihypertensives (Clonidine, Alpha-blockers) | Potentiation of hypotensive effect. | Moderate |
| Warfarin | Amitriptyline may alter anticoagulant effect; monitor INR. | Moderate |
| SSRIs/SNRIs (e.g., Sertraline, Venlafaxine) | Increased risk of serotonin syndrome. | Moderate |
7. Patient Counselling
- DO take the medication exactly as prescribed, usually at bedtime.
- DO inform all your doctors and dentists you are taking this medicine.
- DO keep all follow-up appointments for monitoring.
- DO report any thoughts of self-harm or worsening depression immediately.
- DON'T stop taking this medicine suddenly. Always taper under doctor's guidance.
- DON'T consume alcohol or sleep-inducing OTC medications (e.g., cough syrups).
- DON'T drive or operate machinery until you know how it affects you.
- DON'T take any new prescription, OTC, or herbal medicine without consulting your doctor.
8. Toxicology & Storage
Overdose: Symptoms are severe and potentially fatal, combining TCA and benzodiazepine toxicity: Profound CNS depression (coma), respiratory depression, hypotension, hypothermia, cardiac arrhythmias (widened QRS, ventricular tachycardia, torsades de pointes), seizures, anticholinergic delirium (hallucinations, agitation), decreased bowel sounds, urinary retention. Cardiac toxicity is the major cause of death in TCA overdose.
Storage: Store below 30°C, in a cool, dry place, protected from light and moisture. Keep in the original blister pack or container. Keep out of reach of children and pets. Do not use after the expiry date printed on the pack. Dispose of unused medication safely; do not flush.